The data presented here define that CCDC6, a partner of RET in papillary thyroid carcinoma and in lung adenocarcinoma, fine modulates the CREB1-dependent transcriptional activity through sumoylation both in vitro and in vivo. Here, CREB1 is linked to thyroid gland papillary carcinoma.